Registered Kenya · PPB

ONAPAT EYE DROPS

OLAPATADINE HYDROCHLORIDE

What it does

Olapatadine is a medication used to relieve allergy symptoms such as itchy eyes.

Commonly used for: allergic conjunctivitis, eye allergies

Read more in plain English ↓

Plain-language summary for general understanding - not medical advice. Always follow your pharmacist/doctor.

Ask about this medicine

Answers come only from this medicine's registration record, BNF monograph and interaction data - not medical advice.

Hard to find? We help patients in Kenya source rare medicines. We don't sell or dispense medicines - licensed pharmacies do.

Source this medicine

Registration & product details

Registration no.
H2026/CTD12558/25091
Registration date
-
Expiry date
2031 January 18
Status
Registered
Active ingredient
OLAPATADINE HYDROCHLORIDE
Strength
-
Pack size
5 ML PLASTIC DROPPER BOTTLE WITH PLUG AND CAP
Therapeutic class
GENERIC/BIOSIMILARS
Manufacturer / MAH
Dawa
Applicant / LTR
DAWA LIMITED
Country of origin
FOREIGN
Manufacturer location
Baba Dogo Rd, Nairobi, Kenya

Source: Pharmacy and Poisons Board · fetched 2026-01-28 19:20:05 · updated 2026-11-03 02:07:56

Disclaimer: This information is sourced from Pharmacy and Poisons Board (Kenya). Always consult a qualified healthcare professional before using any medication.

About this medicine

Olapatadine is a medication used to relieve allergy symptoms such as itchy eyes.

What it treats

  • allergic conjunctivitis
  • eye allergies

How it works

Olapatadine works by blocking certain substances in the body that cause allergic reactions, helping to reduce symptoms like itching and redness in the eyes.

Who it's for

This medicine is for people suffering from eye allergies.

AI-assisted summary grounded in BNF data - general information only, not medical advice. Always confirm with your pharmacist or doctor.

Clinical monograph: olapatadine

Olapatadine is a second-generation antihistamine primarily used for the treatment of allergic conjunctivitis and allergic rhinitis. It works by blocking the action of histamine at the H1 receptor, thereby alleviating symptoms such as itching, redness, and swelling associated with allergic reactions.

Indications

  • Allergic conjunctivitis
  • Allergic rhinitis

Dosage

Children: Refer to specific guidelines for pediatric dosing, as it may differ from adult dosing and is contingent upon the specific formulation used.

Adults: Refer to specific guidelines for dosing based on the condition being treated, as dosing may vary between formulations and routes of administration.

Mechanism of action

Olapatadine is a selective H1 antagonist that inhibits the binding of histamine to its receptors. This action reduces the symptoms of allergic reactions. Additionally, olapatadine has been shown to stabilize mast cells, which decreases the release of histamine and other inflammatory mediators.

Pharmacodynamics

Olapatadine exhibits a high affinity for H1 receptors, leading to a decrease in vascular permeability and a reduction in allergic response. Its dual action not only helps relieve immediate allergic symptoms but also contributes to a longer-lasting therapeutic effect by preventing mast cell degranulation.

Pharmacokinetics

Olapatadine is well-absorbed after topical administration. It has a bioavailability that supports its efficacy in treating allergic conditions. The drug undergoes hepatic metabolism, primarily via the cytochrome P450 system, and is excreted mainly in the urine. Its half-life allows for once or twice daily dosing in clinical settings.

Adverse effects

  • Headache
  • Somnolence
  • Dry mouth
  • Nausea
  • Fatigue
  • Dizziness

Precautions

  • Use with caution in patients with renal impairment
  • Monitor for exacerbation of asthma or other respiratory conditions
  • Consider potential for sedation when driving or operating machinery

Pregnancy

Olopatadine should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus, as there are no adequate and well-controlled studies in pregnant women.

Breast-feeding

It is not known whether olopatadine is excreted in human milk. Caution should be exercised when administering to nursing women.

Storage

Store at room temperature, away from light and moisture. Keep out of reach of children.

Formulations

  • Ophthalmic solution
  • Oral tablets
  • Intranasal spray

AI-synthesized from BNF references - general information only, not a substitute for professional medical advice or the current BNF. Verify doses with a pharmacist.